Retatrutide is a potent research peptide primarily studied for its effects on metabolic function and diabetes management. Sourced from superior quality raw materials and synthesized using cutting-edge technology, our Retatrutide ensures top-notch purity and efficacy for detailed and rigorous research.

Retatrutide – GLP‑3 Peptide (commonly termed “Reta”) is a synthetically engineered tri-agonist peptide exhibiting high affinity for the GLP‑1, GIP, and glucagon receptor families.

Key Features:

•   Produced in compliance with the strictest industry standards for purity and consistency.
•   Each batch undergoes stringent quality checks to ensure uniform reliability.
•   Supplied in a lyophilized format to maintain stability and efficacy under recommended storage conditions.

ADDITIONAL INFO:

CAS No.

2381089-83-2 (tel:2381089-83-2)

Purity

≥99%

Sequence

Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-Lys(AEEA-gamma-Glu-C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser

Molecular Formula

C221H342N46O68

Molecular Weight

4731.34 g/mol

Synthesis

Solid-phase synthesis

Format

Lyophilized powder